Measuring Symptom Distress in Cancer Patients

New Assessment System in Measuring Symptom Distress in Cancer Patients

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.

No pharmaceutical medication involved
Patients and healthy individuals accepted


Complete interview

Quality-of-Life Assessment

Complete quality of life assessment

Questionnaire Administration

Complete questionnaires

Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System